PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 9, 2026ChemBioChem2 citations

Structure‐Guided Synthetic Peptide Targeting Nucleolus and Neural Progenitor Protein Nuclear Import Impairs Ribosome Biogenesis and Cancer Cell Proliferation

View Full Paper
AKAbhishek KumarSSSuvam SahaYMYogendra Pratap Mathuria

Key Points

  • The aim is to investigate the role of NEPRO in ribosome biogenesis and its potential as a target for cancer therapy.
  • Identification of a nuclear localization signal (NLS) in NEPRO.
  • Characterization of the impact of a specific mutation (R94C) on NEPRO nuclear localization.
  • Design and testing of a synthetic hexapeptide inhibitor to disrupt NEPRO activity.
  • Assessment of the peptide's effects on cancer cell behavior through cellular delivery and analysis of key markers.
  • The R94C mutation significantly impaired NEPRO's nuclear localization and its interaction with importin-α1.
  • The synthetic hexapeptide inhibitor effectively mislocalized NEPRO to the cytoplasm.
  • Cell treatment demonstrated reduced ribosome activity and collagen secretion.
  • Induction of cell-cycle arrest was observed, alongside increased levels of senescence markers p16 INK4A and p21 WAF1/CIP1.

Abstract

Nucleolus and neural progenitor protein (NEPRO) is a nucleolar factor required for 40S ribosomal subunit maturation and is therefore essential for the high translational demand of proliferating cancer cells. Here, we identify a bipartite nuclear localization signal (NLS; aa 74–96) in NEPRO and show that residues in both basic clusters are required for nuclear targeting. A disease‐associated mutation within the C‐terminal cluster, R94C, abolished NEPRO nuclear localization and markedly reduced binding to importin‐α1 in vitro and in cells. Importin‐α1–NLS complexes revealed that R94 forms persistent hydrogen bonds, salt bridges, and hydrophobic contacts with importin‐α1 residues (A269, W273, P308, T311, P312, N350), explaining its central role in NLS recognition. Guided by these insights, we designed a rational synthetic hexapeptide inhibitor (H 2 N‐AWPTPD‐COOH) that is soluble, monodisperse, shows intrinsic fluorescence and is non‐amyloidogenic. AWPTPD peptide binds wild‐type NEPRO but not the R94C variant, and ab initio modeling shows peptide engagement of the R94 surface. Cellular delivery of the synthetic peptide significantly mislocalized NEPRO to the cytoplasm, reduced polysome abundance, decreased collagen secretion/deposition and clonogenicity, and induced cell‐cycle arrest with upregulation of senescence markers: p16 INK4A and p21 WAF1/CIP1 . These results validate R94 as a targetable hotspot in NEPRO's NLS and demonstrate a peptide‐based approach to perturb ribosome biogenesis and suppress cancer cell growth.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kumar et al. (2026) studied this question.

synapsesocial.com/papers/698979d9f0ec2af6756e7e19https://doi.org/10.1002/cbic.202500799
Ask AI
Helpful
Bookmark
Share
View Full Paper